Citius Pharmaceuticals (CTXR) Q2 2024 Earnings
CTXR·Reported August 12, 2024·Before market open
Diluted EPS came in at $-1.50, missed the $-1.25 consensus by $0.25.
Diluted EPS
$-1.50missed by $0.25
Consensus: $-1.25
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Citius Pharmaceuticals's Q2 2024 earnings report.
Citius Pharmaceuticals (CTXR) reported Q2 2024 earnings on August 12, 2024 before market open.
Citius Pharmaceuticals reported diluted EPS of $-1.50 for Q2 2024.
EPS missed the consensus estimate of $-1.25 by $0.25.
You can read the 10-Q periodic report (0001213900-24-067732) directly on SEC EDGAR. The filing index links above go to sec.gov.